Global Cardiovascular Devices Market Size, Share & Trends Analysis Report by Device Type (Diagnostic Devices(Electrocardiogram (ECG) Devices, Echocardiography Devices, Stress Test Devices),Interventional Devices (Stents, Catheters, Balloon Angioplasty Devices),Surgical Devices(Heart Valve Devices, Implantable Cardioverter Defibrillators (ICDs),Pacemakers),Monitoring Devices(Wearable Devices, Ambulatory Blood Pressure Monitoring Devices)), by Application (Coronary Artery Disease (CAD),Arrhythmias, Heart Failure, Hypertension), by End-User (Hospitals, Ambulatory Surgical Centres (ASCs),Clinics, Home Care), by Technology(Minimally Invasive Technology, Robotic-Assisted Technology, Bioabsorbable Technology)and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) | Forecast [2024-2032] 

The report offers the value (in USD Million) for the above segments.

Region: Global | Format: Word, PPT, Excel | Report Status: Published

 
Global Cardiovascular Devices Market Overview

Global Cardiovascular Devices Market size accrued earnings worth approximately USD 49.51 Billion in 2023 and is predicted to gain revenue of about USD 102.32 Billion by 2032, is set to record a CAGR of nearly 8% over the period from 2024 to 2032.

Cardiovascular disease is one of the most common diseases in the world. According to the American Heart Association, as of January 2024, cardiovascular disease was the number one cause of death in the United States, taking 931,578 lives. It surpasses deaths from all cancers and chronic respiratory diseases put together. This makes cardiovascular devices important for detecting and mitigating heart disorders precisely, hence further fuelling the growth of the market. Rapid technical development, increasing demand for minimally invasive procedures, and affordable and effective devices are the primary driving factors of this market.  The growing number of chronic cardiovascular disorders is adding to the increase in cases and thus is contributing to market growth.

The growing cases of cardiovascular disorders have created the need for increased use of cardiovascular devices. One of the most crucial cardiovascular devices is a heart or coronary artery stent. These help to treat cardiac illnesses, which pose a grave risk to life: heart attacks, coronary disease, atrial fibrillation, and opening blocked arteries. According to WHO statistics from May 2024, CVDs are now the leading cause of disability and premature death in Europe, accounting for more than 42.5% of annual deaths-around 10,000 daily. There is nearly a 2.5-fold difference between males and females in dying of CVDs, with younger people of 30-69 age groups in Eastern Europe and Central Asia almost five times more likely than their peers in Western Europe. The technology being adopted for development of cardiac devices and the indication of these devices have significantly advanced in the last ten years.

Thereby, the cardiology devices are being used to treat a more prominent number of patients; hence, tremendous treatment and monitoring results have been accomplished. In these developments, the most beneficial ones to cardiology are artificial intelligence, which offers more expertise in monitoring specific heart problems. For instance, in May 2024, Medtronic reported AI integration with its Reveal Linq ICM devices into the U.S., Australia, and New Zealand. The AI update is to be introduced in Europe by the end of 2024. The efforts adopted in response to the amplified demands for these devices in emerging nations have also boosted the market.

Wide penetration of sophisticated technologies in developing economies is due to easy access. In October 2024, Boston Scientific Corporation received FDA clearance for its FARAWAVE NAV Ablation Catheter, which is a treatment for paroxysmal atrial fibrillation, as well as the company's clearance for its FARAVIEW Software. These solutions are likely to improve cardiac ablation procedures based on enhanced visualization, and it will only interface with Boston Scientific's cardiac mapping technology, the latest of which is the OPAL HDx Mapping System.

 
Market Drivers

Rising Prevalence of Cardiovascular Diseases (CVDs)

An increasingly growing global incidence of heart diseases, which include coronary artery disease, arrhythmias, and heart failure, poses a greater demand for cardiovascular devices. In fact, since these conditions keep rising with more aging populations and lifestyle factors, such as improper diet and less exercise, there is a strong need for diagnostic, therapeutic, and monitoring advanced devices. There are cardiovascular devices including stents, pacemakers, defibrillators, heart valves, and diagnostic imaging that are applied in diagnosing, treating, and managing the diseases. Stents and pacemakers, for instance, are placed inside the body to facilitate the blood flow and consequently the performance of the heart. Defibrillators, on the other hand, will offer a normal heart rhythm to a person whose arrhythmia is dangerous. Continuous monitoring devices, such as wearable heart rate monitors and implantable devices, make it possible to monitor a patient in real-time and respond to the issues immediately, improving outcomes. Indeed, the demand for these lifesaving devices becomes higher with increased incidence of cardiovascular diseases, which is why these have become integral to modern health care solutions.

 
Market Opportunities

Growth in Remote Monitoring and Wearables

The wearable cardiovascular devices, like smartwatches that monitor heart rate and ECG, and the growth of telemedicine platforms are creating great opportunities in the healthcare market. These devices enable continuous, real-time monitoring of heart health, allowing patients and healthcare providers to track vital signs remotely. These wearables capture data such as heart rate variability, ECG patterns, and other vital parameters that will lead to early diagnosis and timely intervention for detecting problems way before the conditions become serious. Telemedicine complements this by creating avenues through which healthcare personnel can advise via remote consultation, subsequently diagnose and prescribe remedies based on data collected from these wearable devices, improving the access to healthcare of patients-in-need, particularly in regions lacking practicing healthcare professionals. This integration of technology does not only improve patient outcomes but also reduces the need for in-person visits, making healthcare cheaper. Demand for wearable cardiovascular devices and remote monitoring solutions is thus rapidly growing, especially for preventative and chronic disease management.

 
Market Restraining Factors

High Cost of Advanced Cardiovascular Devices

There is a huge disincentive from the high costs of advanced cardiovascular devices, especially heart valves, stents, and implantable defibrillators, as they are known to be very expensive, especially to low-income countries and developing areas. The cost of the device is usually costly to manufacture and even research, which means that the patients or the healthcare systems often pay highly. Such costs can be a limiting factor in relation to accessing life-prolonging therapy in regions with limited budgets for healthcare, leaving most people without the necessary interventions into heart conditions. In addition, such expensive prices can strain public health systems, especially in countries where there is little reimbursement or insurance coverage for such devices. This financial constraint limits the availability of modern cardiovascular treatments, and patients will thus have worse health outcomes and a higher mortality rate from preventable heart diseases. As such, the market for cardiovascular devices experiences slower growth in these regions, which limits the penetration globally and slows down the overall progress of cardiovascular healthcare.

 
Segmentation Analysis

The market scope is segmented because of by Device Type, by Application, by End-User, by Technology, by region.

By Device Type

Based on the Device Type of the market is segmented into Diagnostic Devices (Electrocardiogram (ECG) Devices, Echocardiography Devices, Stress Test Devices), Interventional Devices (Stents, Catheters, Balloon Angioplasty Devices), Surgical Devices (Heart Valve Devices, Implantable Cardioverter Defibrillators (ICDs), Pacemakers), Monitoring Devices (Wearable Devices, Ambulatory Blood Pressure Monitoring Devices).

The Cardiovascular Devices Market is dominated by Interventional Devices, closely followed by diagnostic and monitoring devices, because of the need for management of heart disease among most people. Essential components of the line of products offered under Interventional Devices are Stents, Catheters, and Balloon Angioplasty Devices. For instance, stents ensure that there is a continued improvement in blood flow due to the keeping open of arteries after angioplasty. Diagnostic Devices include Electrocardiogram (ECG) Devices, Echocardiography Devices, and Stress Test Devices. These devices are critical in the detection and diagnosis of heart-related conditions. ECG devices monitor heart rhythms, while echocardiography provides real-time heart imaging to assess function. Surgical Devices include Heart Valve Devices, Implantable Cardioverter Defibrillators (ICDs), and Pacemakers. For instance, pacemakers regulate heartbeats in patients with abnormal rhythms. Monitoring Devices: These include ambulatory blood pressure monitoring devices as well as wearable devices like smart watches that track heart rates. Such monitoring devices keep patients with chronic conditions under surveillance, and help in detecting and controlling disease at its early stages. It is an absolute necessity when it comes to high-risk patients.

By Application

Based on the Application of the market is segmented into coronary artery disease (CAD), Arrhythmias, Heart Failure, Hypertension.

CAD represents the leading disease in the cardiovascular market. The disease results in a lot of heart attacks, and so intervention is substantial. CAD arises due to narrowed or blocked coronary arteries because of the accumulation of plaque, causing decreased blood supply to the heart. The drugs prescribed for treatment are stents and balloon angioplasty instruments used to clear out the obstructed arteries. Another critical issue is arrhythmias, or irregular heart rhythms, that often cause stroke or heart failure. Pacemakers and ICDs are the most commonly used devices for regulating heartbeats and preventing sudden cardiac arrest. Heart failure is a progressive condition in which the heart is unable to pump enough blood to meet the needs of the body. It may be due to CAD or other causes, and medical devices such as heart valves and left ventricular assist devices (LVADs) are frequently used in the treatment of this condition. Another major risk factor for cardiovascular diseases is hypertension, or high blood pressure. Ambulatory blood pressure monitors are useful in monitoring blood pressure over time, thus facilitating early detection and management of this condition. This underscores the increasing needs for sophisticated devices in cardiovascular systems.

Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America has a major share as the region has more developed healthcare setup, higher health care spending, and the prevalence of cardiovascular diseases. U.S. has an established market for cardiovascular devices. The population demographics are characterized by an aging population, with a high incidence rate of heart diseases such as coronary artery disease, arrhythmias, and heart failure. Strong regulatory support in the form of FDA approvals for innovative devices also fuels this market's growth.

Europe comes close, too: Germany, France, and the UK add to growth within the market. The aging of the population in Europe, coupled with solid health care systems, further drives up demand for cardiovascular devices, particularly for diagnostic, interventional, and monitoring types. Additionally, the region benefits from more definitive regulatory policies set by the European Medicines Agency, thereby maintaining the safety and efficacy of cardiovascular technologies.

There is an increasing trend of cardiovascular diseases in the Asia-Pacific region, which is undergoing rapid urbanization and improvement in health care infrastructure. Cardiac disease cases in China, India, and Japan are showing growth, hence the more demand for diagnostic and interventional devices. Private healthcare expansion, combined with government initiatives in improving access to healthcare, accelerates the growth of the market in this region. The large population base and growing awareness about heart health are also drivers for Asia-Pacific.

Latin America and Middle East & Africa have lower growth, but promise to increase health spending, growing consciousness, and infrastructure development in the medical sector. Examples are Brazil and Mexico where increasing health coverage would expand the uptake of cardiovascular devices. Middle East countries such as UAE and Saudi are targeting investments in health technologies that include cardiovascular care also.

 
List of Companies Profiled
  • Abbott
  • GE HealthCare
  • Edwards Lifesciences Corporation
  • L. Gore & Associates, Inc.
  • Siemens Healthcare GmbH
  • BIOTRONIK SE & Co. KG
  • Canon Medical Systems Asia Pte. Ltd.
  • Braun SE
  • LivaNova PLC
  • Cardinal Health
  • Medtronic
  • Boston Scientific Corporation.
 
Report Coverage

The report will cover the qualitative and quantitative data on the Global Cardiovascular Devices Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

 
Report Scope and Segmentations

Study Period

2024-32

Base Year

2023

Estimated Forecast Year

2024-32

Growth Rate

CAGR of 8% from 2024 to 2032

Segmentation

By Device Type, By Application, By End-User, By Technology, By Region

Unit

USD Million

By Device Type

  • Diagnostic Devices

·       Electrocardiogram (ECG) Devices

·       Echocardiography Devices

·       Stress Test Devices

  • Interventional Devices

·       Stents

·       Catheters

·       Balloon Angioplasty Devices

  • Surgical Devices

·       Heart Valve Devices

·       Implantable Cardioverter Defibrillators (ICDs)

·       Pacemakers

  • Monitoring Devices

·       Wearable Devices

·       Ambulatory Blood Pressure Monitoring Devices

By Application

  • Coronary Artery Disease (CAD)
  • Arrhythmias
  • Heart Failure
  • Hypertension

By End-User

  • Hospitals
  • Ambulatory Surgical Centres (ASCs)
  • Clinics
  • Home Care

By Technology

  • Minimally Invasive Technology
  • Robotic-Assisted Technology
  • Bioabsorbable Technology

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Asia-Pacific (China, India, Japan, ASEAN, Rest of Asia-Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • MEA (Saudi Arabia, South Africa, UAE, Rest Of MEA)

 

Global Cardiovascular Devices Market Regional Analysis

North America accounted for the highest xx% market share in terms of revenue in the Cardiovascular Devices market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Cardiovascular Devices. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Cardiovascular Devices companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Cardiovascular Devices Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Cardiovascular Devices Market Report is also available for below Regions and Country Please Ask for that

North America

  • U.S
  • Canada

Europe

  • Switzerland
  • Belgium
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Rest of Europe

Asia-Pacific

  • India
  • Australia
  • Philippines
  • Singapore
  • South Korea
  • Japan
  • China
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Argentina
  • Peru
  • Colombia
  • Brazil
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA
 
Points Covered in the Report
  • The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
  • The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
  • The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
  • Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
  • The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

 

Key Questions
  • How much the global Cardiovascular Devices Market valued?
  • Which region has the largest share in 2024 for the global Cardiovascular Devices Market?
  • What are the driving factors for the market?
  • Which is the leading segment in the global market?
  • What are the major players in the market?

 

Research Scope of Cardiovascular Devices Market
  • Historic year: 2019- 2022
  • Base year: 2023
  • Forecast: 2024 to 2032
  • Representation of Market revenue in USD Billion


Cardiovascular Devices Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:

  • PUBLISHED ON : March, 2023
  • BASE YEAR : 2023
  • STUDY PERIOD : 2020-2032
  • COMPANIES COVERED : 20
  • COUNTRIES COVERED : 25
  • NO OF PAGES : 380

Want to Review Complete Market Research Report

 $2800
 $4200
  $5600

Budget constraints? Get in touch with us for special pricing


Customize this Report

  • Buy specific segmentations (By Market Vertical, By Product Type) of this report
  • Buy specific region/country level reports
  • Request for Product Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • 20+ Company Profiles based on Project Requirement
  • Regulatory Analysis & Case Studies for Marketing Review
  • Competitive Landscape Analysis as per Client Requirement
  • Total Report Customization with Research Team Consultation
  • Why Choose Intellectual Market Insights?
  • Regional and Country Analysis
  • Parent/Child Market Analysis
  • SWOT analysis
  • Real-Time Market Attractiveness Index
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Product and penetration rate of segments. Policies and regulations analysis
  • Profiles of key companies operating in the market
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Supply and Demand analysis
  • Financial Overview of Companies
  • Primary research (conducting interviews with CXO levels)
  • Marketing Survey
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization